-   Article AERZEN Management focuses on the future

Klaus-Hasso Heller moves to the supervisory board

A change in management is taking place at Aerzener Maschinenfabrik GmbH. CEO Klaus-Hasso Heller will be taking over the chairmanship of the AERZEN Supervisory Board in May 2020. Klaus-Hasso Heller’s successor as Commercial Managing Director of Aerzener Maschinenfabrik GmbH will be Dr. Carsten Bruns.

In 2000, Klaus-Hasso Heller took over the management of the company from his father Hasso Heller, which at that time had a turnover of around €110 million. The company, under Klaus-Hasso Heller, has grown to over 50 subsidiaries worldwide (there were 13 in 2000) and a turnover of €450 million. Since 2000, the number of employees in the group has risen from 1,225 to around 2,500 today. “AERZEN has a solid base because we have achieved a great performance through the hard work of all executives and employees,” says the graduate industrial engineer as he looks back on his years as CEO. I have therefore made the decision to concentrate fully on strategic corporate development and future orientation as Chairman of the Supervisory Board in the future and thus to shape the direction over the next few years of our family-owned company,” explains Klaus-Hasso Heller in respect of the forthcoming change. The objective of the shareholders is to maintain the company as a family-owned enterprise.

The individuals who will be responsible for the management of Aerzener Maschinenfabrik GmbH in future are Klaus Peter Glöckner (Managing Director Sales and future Chairman of the Management Board) and Björn Irtel (Managing Director Operations) – both are long-serving and very experienced senior executives of the company. The third member of the trio is new Commercial Managing Director, Dr. Carsten Bruns, who will be responsible for Finance, IT, Personnel, Compliance and Legal Affairs. The business graduate had been responsible for these areas for the past 13 years as a member of the Executive Board of the family-run diagnostics group R-Biopharm AG. Dr. Carsten Bruns’ other professional positions include RWE AG, the family business CLAAS KGaA mbH and Deutsche Telekom AG. The 49 year old was also active in the commercial sector at each of these companies, with a focus on M & A (Mergers & Acquisitions).

Klaus Peter Glöckner will be responsible for Sales, Marketing and After-Sales in future, while Björn Irtel, as Managing Director Operations, will continue to head the Production, Technology, Quality, Purchasing and Process Gas divisions. “I am pleased about this constellation, because with them we have an extremely powerful team, and they will complement each other very well,” says Klaus-Hasso Heller about the new management of Aerzener Maschinenfabrik.